89bio Revenue vs. Return On Equity
| ETNB Stock | USD 8.96 0.20 2.28% |
Total Revenue | First Reported 2019-03-31 | Previous Quarter 0.0 | Current Value 0.0 | Quarterly Volatility 48.8 K |
For 89bio profitability analysis, we use financial ratios and fundamental drivers that measure the ability of 89bio to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well 89bio Inc utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between 89bio's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of 89bio Inc over time as well as its relative position and ranking within its peers.
89bio |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 89bio. If investors know 89bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 89bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.96) | Return On Assets (0.41) | Return On Equity (0.73) |
The market value of 89bio Inc is measured differently than its book value, which is the value of 89bio that is recorded on the company's balance sheet. Investors also form their own opinion of 89bio's value that differs from its market value or its book value, called intrinsic value, which is 89bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 89bio's market value can be influenced by many factors that don't directly affect 89bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 89bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if 89bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 89bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
89bio Inc Return On Equity vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining 89bio's current stock value. Our valuation model uses many indicators to compare 89bio value to that of its competitors to determine the firm's financial worth. 89bio Inc is currently under evaluation in revenue category among its peers. It is rated # 2 in return on equity category among its peers . At present, 89bio's Total Revenue is projected to stay steady based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the 89bio's earnings, one of the primary drivers of an investment's value.89bio Revenue vs. Competition
89bio Inc is currently under evaluation in revenue category among its peers. Market size based on revenue of Health Care industry is currently estimated at about 145.81 Million. 89bio adds roughly 0.0 in revenue claiming only tiny portion of equities under Health Care industry.
89bio Return On Equity vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
89bio |
| = | null |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
89bio |
| = | -0.73 |
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
89bio Return On Equity Comparison
89bio is currently under evaluation in return on equity category among its peers.
89bio Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in 89bio, profitability is also one of the essential criteria for including it into their portfolios because, without profit, 89bio will eventually generate negative long term returns. The profitability progress is the general direction of 89bio's change in net profit over the period of time. It can combine multiple indicators of 89bio, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 190 K | 199.5 K | |
| Operating Income | -151.2 M | -143.6 M | |
| Net Loss | -126.6 M | -120.2 M | |
| Income Before Tax | -138.3 M | -131.4 M | |
| Total Other Income Expense Net | 12.9 M | 13.5 M | |
| Net Loss | -91.8 M | -96.4 M | |
| Net Loss | -142.2 M | -135.1 M | |
| Income Tax Expense | 3.9 M | 4.1 M | |
| Non Operating Income Net Other | 2.5 M | 2.6 M | |
| Net Interest Income | 8.8 M | 9.3 M | |
| Interest Income | 13.3 M | 14 M | |
| Change To Netincome | 9.3 M | 8.9 M | |
| Net Loss | (2.00) | (2.10) | |
| Income Quality | 0.91 | 0.62 | |
| Net Income Per E B T | 1.03 | 0.81 |
89bio Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on 89bio. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of 89bio position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the 89bio's important profitability drivers and their relationship over time.
Use 89bio in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if 89bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 89bio will appreciate offsetting losses from the drop in the long position's value.89bio Pair Trading
89bio Inc Pair Trading Analysis
The ability to find closely correlated positions to 89bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace 89bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back 89bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling 89bio Inc to buy it.
The correlation of 89bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as 89bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if 89bio Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for 89bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your 89bio position
In addition to having 89bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Corporate Bonds Funds Thematic Idea Now
Corporate Bonds Funds
Funds or Etfs investing in different types of corporate debt instruments. The Corporate Bonds Funds theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Corporate Bonds Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Investing Opportunities. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
To fully project 89bio's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of 89bio Inc at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include 89bio's income statement, its balance sheet, and the statement of cash flows.